Organon (OGN) Return on Invested Capital (2021 - 2026)

Organon has reported Return on Invested Capital for 6 years, with the latest figure at 0.03% in Q2 2026.

• Return on Invested Capital for Q2 2026 came in at 0.03%, down 9.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 0.03% (down 9.0% YoY), and the FY2025 annual result was 0.28%, down 80.0% from the prior year.
• Return on Invested Capital advanced to 0.03% in Q2 2026, from 0.03% in the prior quarter.
• Over five years, Return on Invested Capital peaked at 0.28% in Q1 2025 and troughed at 0.89% in Q1 2024.
• A 5-year average of 0.19% and a median of 0.1% in 2022 frame the typical range for Return on Invested Capital.
• The widest annual swing landed in 2023, when Return on Invested Capital tumbled 57 bps; it then soared 117 bps in 2025.
• A 5-year view of Return on Invested Capital shows it stood at 0.29% in 2022, then plunged by 198 bps to 0.86% in 2023, then soared by 119 bps to 0.17% in 2024, then sank by 85 bps to 0.03% in 2025, then grew by 11 bps to 0.03% in 2026.
• Per Business Quant data, the three most recent Return on Invested Capital figures were 0.03% in Q2 2026, 0.03% in Q1 2026, and 0.03% in Q4 2025.